ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00664586
Recruitment Status : Terminated (Funding constraints)
First Posted : April 23, 2008
Last Update Posted : February 23, 2016
Sponsor:
Information provided by (Responsible Party):
Erimos Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : April 2009
  Actual Study Completion Date : June 2009